BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2296 related articles for article (PubMed ID: 15367383)

  • 1. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction.
    Sinico C; Manconi M; Peppi M; Lai F; Valenti D; Fadda AM
    J Control Release; 2005 Mar; 103(1):123-36. PubMed ID: 15710506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
    Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
    Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
    Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
    J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of hydrocortisone from liposomal suspensions to the hairless mouse skin following topical application under non-occlusive and occlusive conditions.
    Kim MK; Chung SJ; Lee MH; Shim CK
    J Microencapsul; 1998; 15(1):21-9. PubMed ID: 9463804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.
    Manconi M; Sinico C; Valenti D; Lai F; Fadda AM
    Int J Pharm; 2006 Mar; 311(1-2):11-9. PubMed ID: 16439071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of drug release from liposomal formulations in ocular fluid.
    Jafari MR; Jones AB; Hikal AH; Williamson JS; Wyandt CM
    Drug Deliv; 1998; 5(4):227-38. PubMed ID: 19569989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization and skin permeation of liposome formulations containing clindamycin phosphate.
    Shanmugam S; Song CK; Nagayya-Sriraman S; Baskaran R; Yong CS; Choi HG; Kim DD; Woo JS; Yoo BK
    Arch Pharm Res; 2009 Jul; 32(7):1067-75. PubMed ID: 19641889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery.
    Dubey V; Mishra D; Jain NK
    Eur J Pharm Biopharm; 2007 Sep; 67(2):398-405. PubMed ID: 17452098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: creation of a drug supersaturated state.
    Barichello JM; Handa H; Kisyuku M; Shibata T; Ishida T; Kiwada H
    J Control Release; 2006 Sep; 115(1):94-102. PubMed ID: 16919352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phycocyanin liposomes for topical anti-inflammatory activity: in-vitro in-vivo studies.
    Manconia M; Pendás J; Ledón N; Moreira T; Sinico C; Saso L; Fadda AM
    J Pharm Pharmacol; 2009 Apr; 61(4):423-30. PubMed ID: 19298687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of liposomal systems of finasteride for topical applications: design, characterization, and in vitro evaluation.
    Kumar R; Singh B; Bakshi G; Katare OP
    Pharm Dev Technol; 2007; 12(6):591-601. PubMed ID: 18161632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models.
    Tabbakhian M; Tavakoli N; Jaafari MR; Daneshamouz S
    Int J Pharm; 2006 Oct; 323(1-2):1-10. PubMed ID: 16837150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of minoxidil-loaded liposomal system for delivery to pilosebaceous units.
    Jain B; Singh B; Katare OP; Vyas SP
    J Liposome Res; 2010 Jun; 20(2):105-14. PubMed ID: 19698000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of in-vivo topical anti-inflammatory activity of indometacin from liposomal vesicles.
    Puglia C; Trombetta D; Venuti V; Saija A; Bonina F
    J Pharm Pharmacol; 2004 Oct; 56(10):1225-32. PubMed ID: 15482636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicular carriers for dermal drug delivery.
    Sinico C; Fadda AM
    Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miconazole nitrate bearing ultraflexible liposomes for the treatment of fungal infection.
    Pandit J; Garg M; Jain NK
    J Liposome Res; 2014 Jun; 24(2):163-9. PubMed ID: 24479833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis.
    Gupta M; Goyal AK; Paliwal SR; Paliwal R; Mishra N; Vaidya B; Dube D; Jain SK; Vyas SP
    J Liposome Res; 2010 Dec; 20(4):341-50. PubMed ID: 20163329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of a pineal hormone: melatonin via elastic liposomes.
    Dubey V; Mishra D; Asthana A; Jain NK
    Biomaterials; 2006 Jun; 27(18):3491-6. PubMed ID: 16513163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 115.